Indore

IPCA now plus Rs.2700 Crores Company is global player with significant presence in over 110 countries with high brand equity in the domestic and international markets Our manufacturing facilities of bulk drugs at Ratlam have earned accreditations and approvals from the worlds most vigilant regulatory bodies.

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs nearly 6000 people in over 80 countries. It has twelve manufacturing facilities in four countries and has five R&D centres.

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies. We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have significant worldwide presence in specialty therapeutic areas such as cardiology, neurology, diabetology, etc. We have also plans for expansion in Ophthalmic etc.

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country. Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

The flagship company of the Piramal Group, Piramal Enterprises Ltd. (PEL), has business interests in Pharma, Information Management, and Financial Services verticals of the group.  Towards the late 80s, we shifted our focus from textile to pharmaceuticals. We chose to invest significantly in the domestic formulation development business, while other companies in the industry concentrated on international generics. Our efforts proved successful with a track record of approximately 23% revenue CAGR. In 2010, our strategy accomplished a sale of its domestic formulations business at an unprecedented value of ~9x sales and ~30x EBITDA.

Mathuradevi Institute Pharmacy is established by Gyan Vigyan Krida Vikas Sansthan, Indore is supported by academicians & industrialists of the country.The institution is working towards becoming a centre of excellence in pharmaceutical education and research and will be the leader in the field of pharmaceutical sciences and pharmacy practice with a vision of strengthening the healthcare of the country.

Post : ASST. PROF. FOR PHARM. CHEMISTRY, PHARMACOLOGY, PHARMACEUTICS 03 POST

Zydus Cadila is a professionally managed public company offering immense opportunities to learn and grow. This ability to evolve, gain new capabilities and raise the bar of excellence forms the heart of our success. We provide an environment where people come and give their best not because they have to, but because they want to. At Zydus we build people to build our business.

Our goal is to provide the world's 7 billion people with access to high quality medicine. What is yours? Mylan is one of the world's leading generic pharmaceutical company, providing products in around 165 countries, though our global workforce of more than 35,000 passionate leaders. If you resonate with our audacious ambition to provide the world's 7 billion population with access to high quality medicine, with state-of-the-art, Finished Dosage Forms (FDF) manufacturing facilities at Indore. This facility is compliant of USFDA, WHO,MHRA, MCC, and ANVISA. Mylan Laboratories is keen to attract talent for the Departments and Post:

Modern Institute of Pharmaceutical Sciences (MIPS), Indore was established in 2007. With intent to establish an institution of repute for creating technical experts and to translate their potential to meet the requirements of Pharmaceutical Industries and meet the global challenges faced by them. MIPS shall endeavor to impart theoretical lectures coupled with practical training and understanding of pharmaceutical industry.